A Study of Compare the Pharmacokinetic, Pharmacodynamic and Safety/Tolerability Characteristics Following Multiple Oral Administration of AD-234, AD-2341, and AD-2342 in Healthy Adults
Clinical trial NCT07717775 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07717775
- Sponsor
- Addpharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2026-11-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.